Fan Xiaoyan, Jin Yuelei, Chen Guang, Ma Xueqiang, Zhang Lixia
Department of Basic Medical Sciences, Taizhou University Hospital, Taizhou University, Taizhou, China.
Department of Neurology, Taizhou Second People's Hospital, Taizhou, China.
Digestion. 2021;102(4):508-515. doi: 10.1159/000508328. Epub 2020 Sep 15.
The gut microbiota is a diverse community of microbes that maintain the stability of the intestinal environment. Dysbiosis of the gut microbiota has been linked to gastrointestinal diseases, such as colorectal cancer (CRC) - a leading cause of death for cancer patients.
Candidate pathogens have been identified using bacterial culture and high-throughput sequencing techniques. Currently, there is evidence to show that specific intestinal microbes drive CRC development and progression, yet their pathogenic mechanisms are still unclear. Key Messages: In this review, we describe the known healthy gut microbiota and its changes in CRC. We especially focus on exploring the pathogenic mechanisms of gut microbiota dysbiosis in CRC. This is crucial for explaining how gut microbiota dysbiosis drives the process of colorectal carcinogenesis and tumor progression. Evaluation of changes in the gut microbiota during CRC development and progression offers a new strategy for the diagnosis and treatment of this disease.
肠道微生物群是一个多样的微生物群落,维持着肠道环境的稳定性。肠道微生物群失调与胃肠道疾病有关,如结直肠癌(CRC)——癌症患者的主要死因。
已使用细菌培养和高通量测序技术鉴定出候选病原体。目前,有证据表明特定的肠道微生物会驱动结直肠癌的发生和发展,但其致病机制仍不清楚。关键信息:在本综述中,我们描述了已知的健康肠道微生物群及其在结直肠癌中的变化。我们特别关注探索肠道微生物群失调在结直肠癌中的致病机制。这对于解释肠道微生物群失调如何驱动结直肠癌的发生和肿瘤进展过程至关重要。评估结直肠癌发生和发展过程中肠道微生物群的变化为该疾病的诊断和治疗提供了新策略。